MacroChem Corporation
News published by MacroChem Corporation officials updates activities
Published in Lab Business Week, September 23rd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at MacroChem Corporation.
Report 1: MacroChem Corporation (OTCBB: MACM) announced that it has signed an exclusive option to acquire exclusive worldwide license rights for drug uses of pexiganan, a novel, small peptide anti-infective for topical treatment of patients with mild diabetic foot infection (DFI), from Genaera Corporation (Genaera).
"We believe this is a unique opportunity for MacroChem to broaden its product portfolio with a product that has already...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-09-23)
More Articles from Lab Business Week
- Arrhythmia
Circulation Publishes Study from Masonic Medical Research Laboratory Suggesting a New Strategy for the Treatment of Atrial Fibrillation - Biological Chemistry
New biological chemistry study findings have been reported from Cold Spring Harbor Laboratory - Bird Flu
Carrington Reports on ISO 9001:2000 Inspection at Sabila Industrial in Costa Rica - Financials
BioReference Laboratories, Inc. Announces 35% Increase in Net Revenues, 50% Increase in Operating Income, Year Over Year - Hypertension
Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension - Non-Small Cell Lung Cancer
Aureon Laboratories Completes Initial Study with AstraZeneca Using Predictive Pathology to Stratify Patient Risk for Non-Small Cell Lung Cancer - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
